LRBa1898/1
MPG:amn
2015 - 2016 LEGISLATURE
SENATE AMENDMENT 1,
TO SENATE BILL 716
February 10, 2016 - Offered by Senator Darling.
SB716-SA1,1,11 At the locations indicated, amend the bill as follows:
SB716-SA1,1,4 21. Page 2, line 2: delete "Beginning in 2017, no later than October 1 of each
3year," and substitute "Beginning with the 3rd calendar quarter of 2016, no later than
430 days after the end of each calendar quarter,".
SB716-SA1,1,5 52. Page 2, line 11: delete "October 1, 2020" and substitute "October 30, 2020".
SB716-SA1,1,6 63. Page 3, line 1: delete lines 1 to 5 and substitute:
SB716-SA1,1,9 7"961.385 (6) Beginning with the 3rd calendar quarter of 2016, no later than 30
8days after the end of each calendar quarter, the board shall provide a report to the
9department of safety and professional services that includes all of the following:".
SB716-SA1,1,10 104. Page 3, line 5: delete "November 1, 2020" and substitute "October 30, 2020".
SB716-SA1,1,11 115. Page 3, line 9: after "program" insert "in the previous quarter".
SB716-SA1,1,12 126. Page 3, line 11: after "(a)" insert "in the previous quarter".
SB716-SA1,2,1
17. Page 3, line 12: after "requests" insert "made in the previous quarter".
SB716-SA1,2,3 28. Page 3, line 16: after "period" insert "at any time over the course of the
3program".
SB716-SA1,2,4 49. Page 3, line 19: after "milligrams" insert "in the previous quarter".
SB716-SA1,2,6 510. Page 3, line 21: after "period" insert "at any time over the course of the
6program".
SB716-SA1,2,7 711. Page 3, line 21: after that line insert:
SB716-SA1,2,8 8" Section 2r. 961.385 (7s) of the statutes is created to read:
SB716-SA1,2,129 961.385 (7s) (a) The board may contract with an analytics firm to augment the
10program under this section with an analytics platform that provides data
11integration, advanced analytics, and alert management capabilities to detect
12problematic behaviors of practitioners, pharmacies, pharmacists, and patients.
SB716-SA1,2,1413 (b) If the board augments the program under this section as specified in par.
14(a), the goals of that augmentation shall include all of the following:
SB716-SA1,2,1615 1. Allowing the board, with the assistance of the analytics firm, to identify past
16patterns of abuse, addiction, or criminal activity.
SB716-SA1,2,1817 2. Proactively improving painkiller prescribing, informing clinical practice,
18and protecting patients at risk.
SB716-SA1,2,2019 3. Measuring program outcomes at an individual level to minimize the abuse
20of monitored prescription drugs in this state.
SB716-SA1,2,2221 (c) For purposes of this subsection, the board may disclose records generated
22under the program to an analytics firm with which the board contracts.".
Loading...
Loading...